Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy. - Wikidata - awgldk - TriplyDB

Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.

Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.

http://www.wikidata.org/entity/Q41110002

about

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma ATF2 translation is induced under chemotherapeutic drug-mediated cellular stress via an IRES-dependent mechanism in human hepatic cancer Bel7402 cells Recent advances in hepatocellular carcinoma therapy.Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro Effect of Combined Treatment Using Wilfortrine and Paclitaxel in Liver Cancer and Related Mechanism.RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer.Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs.Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention.Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer.

P2860

Q26745710-22BE457D-1C45-4919-AB2E-CA303E2F78FD Q28068437-A6EF8317-EECA-4B33-AB99-36CB13313F8E Q28468346-DD3127A1-E7B5-48C9-BC5A-9ED4C4679E01 Q30236010-B3471B6A-00A4-45AD-868D-1B207A05D9FA Q36965059-CC8511BD-F56E-44A7-A29C-ABDDD1E658AD Q38780817-D16B6B2D-B46B-48B4-A596-9BF819F81828 Q42799162-475AD15C-D5AE-4B7C-AC19-4B438634474A Q45064375-52F2B530-5FDF-446F-A290-D903CA840858 Q47142649-FBE6D2C4-7351-4088-9617-979D50B1A357 Q55285429-BE746F88-EECF-43A8-8A48-9D7CF3B6E348

P2860

Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.

http://www.wikidata.org/entity/Q41110002

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effect of integrin receptor-ta ...... rcinoma targeting and therapy.

@en

type

label

Effect of integrin receptor-ta ...... rcinoma targeting and therapy.

@en

prefLabel

Effect of integrin receptor-ta ...... rcinoma targeting and therapy.

@en

P1433

Q41110002-8970BD61-2109-48CB-BD54-09234EB4BF7E

P1476

Q41110002-91A91B97-C051-4D94-9FD7-7BCCF11DAC54

P2093

Q41110002-231F5A35-F08F-4839-A748-7A27869DC292

Q41110002-4B8C1AC6-0AD4-4426-8CC4-2DA16508B07D

Q41110002-CDDDCE50-B217-4F9D-BEB0-F14DF397D17E

Q41110002-D6DEC573-0AEC-4E88-8750-364638FAE30F

P2860

Q41110002-015B3724-9A0F-436E-AC6D-B32AC1354CF6

Q41110002-0215907D-1335-4BE7-A52A-6D110E2FCA7F

Q41110002-07DE4747-2F15-4085-94D2-A2B5EC3662D9

Q41110002-0D2D3EA6-310A-4E2A-8C84-D4DDC89E700F

Q41110002-1CF2052E-EBDE-40AD-9C6E-0D963210F0AD

Q41110002-1D9442DC-4DEC-4D3E-B1F6-FE0BB0D236C5

Q41110002-3C8A8855-7887-4EF2-8CF8-E81E27599FB5

Q41110002-45E0C3CD-5431-4D17-91E7-8696B8FEDF9D

Q41110002-4BC344CF-F3D4-4AF4-9F6F-1ED09D24368C

Q41110002-542741FF-123E-4236-AE2E-BCB2D744DEF5

P304

Q41110002-92687788-7D61-4759-A72D-F07B75607361

P31

Q41110002-B4C21431-4131-419A-8CBE-9C8C802CAC11

P356

Q41110002-D6E62D03-4AD6-49CB-A527-1459395633BE

P433

Q41110002-F1299A38-4C55-46B2-9351-9B8E3232C45C

P478

Q41110002-97F6AD92-CA80-4C78-85FA-4FD1179F703A

P577

Q41110002-52CBC364-D34E-4021-BE84-73496835560D

P5875

Q41110002-1E0BC88E-6439-4DF0-B319-AB59A96A5C6B

P698

Q41110002-9BF7DEA4-3080-4BE8-92F4-D97CFE9E25AF

P932

Q41110002-E346B69F-2443-4A88-ACBF-1A33E5AE1AAD

P356

P1433

Oncology Letters

P1476

Effect of integrin receptor-ta ...... rcinoma targeting and therapy.

@en

P2093

Kai Liu

http://www.w3.org/2001/XMLSchema#string

Liyu Chen

http://www.w3.org/2001/XMLSchema#string

Weiya Wang

http://www.w3.org/2001/XMLSchema#string

Yanbin Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct role of macrophages in different tumor microenvironments

Hepatocellular carcinoma pathogenesis: from genes to environment

Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.

Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Delivery of molecular and cellular medicine to solid tumors.

Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.

Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells.

A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma.

Inhibitory effect of endostatin combined with paclitaxel-cisplatin on breast cancer in xenograft-bearing mice

The design of guanidinium-rich transporters and their internalization mechanisms.

P304

77-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.3242

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277905818

http://www.w3.org/2001/XMLSchema#string

P698

26170980

http://www.w3.org/2001/XMLSchema#string

P932

4487032

http://www.w3.org/2001/XMLSchema#string